Compounds > gw420867x
Page last updated: 2024-09-04

gw420867x and hby 097

gw420867x has been researched along with hby 097 in 1 studies

Compound Research Comparison

Studies
(gw420867x)		Trials
(gw420867x)		Recent Studies (post-2010)
(gw420867x)		Studies
(hby 097)		Trials
(hby 097)		Recent Studies (post-2010) (hby 097)
17522250

Protein Interaction Comparison

ProteinTaxonomygw420867x (IC50)hby 097 (IC50)
Chain A, REVERSE TRANSCRIPTASEHuman immunodeficiency virus 10.3225
Chain B, REVERSE TRANSCRIPTASEHuman immunodeficiency virus 10.3225
Chain A, REVERSE TRANSCRIPTASEHuman immunodeficiency virus 10.3225
Chain B, REVERSE TRANSCRIPTASEHuman immunodeficiency virus 10.3225
Gag-Pol polyproteinHIV-1 M:B_HXB2R0.0243

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jorgensen, WL; Kroeger Smith, MB; Rizzo, RC; Smith, RH; Tirado-Rives, J; Udier-Blagović, M; Wang, DP; Watkins, EK1

Other Studies

1 other study(ies) available for gw420867x and hby 097

ArticleYear
Prediction of activity for nonnucleoside inhibitors with HIV-1 reverse transcriptase based on Monte Carlo simulations.
    Journal of medicinal chemistry, 2002, Jul-04, Volume: 45, Issue:14

    Topics: Alkynes; Anilides; Benzoxazines; Computer Simulation; Cyclopropanes; HIV Reverse Transcriptase; Hydrogen Bonding; Models, Molecular; Monte Carlo Method; Nevirapine; Oxazines; Protein Binding; Quinoxalines; Regression Analysis; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Uracil

2002